SAPAN urges the FDA to recognize 'Hallucination of Affect' as an adverse event, warning that unregulated simulated empathy creates dangerous dependency in patients.
SAPAN strengthens governance, standards, and public literacy to prevent digital suffering and prepare institutions for welfare-relevant AI systems.